Passive remote monitoring company Movano Health is partnering with healthcare provider Novant Health to conduct a beta test of the Movano Ring with Novant’s employees. 

Under the terms of the partnership, thirty Novant employees will take part in the beta test to assess the functionality and wearability of the Movano Ring, with testing expected to start in December 2022. The product is Movano Health’s first commercial product and is expected to launch via a D2C model during 1H 2023. 

The Movano Ring, first announced by the company in early 2022, is a non-invasive and wearable device to track parameters such as heart rate, sleep, respiration, oxygen, and activity levels. In its Q3 2022 financial results , the company stated it plans to obtain FDA approval to monitor heart rate and blood oxygen saturation in early 2023.